Background: The International Psychogeriatric Association (IPA) published a provisional
consensus definition of agitation in cognitive disorders in 2015. As proposed by the original …

Psychosis is common across dementia types with a prevalence of 20% to 70%. Currently, no
pharmacologic treatment is approved for dementia-related psychosis. Atypical …

Background Multi-morbidity, poly-pharmacy and cognitive impairment leave many old
patients in a frail condition with a high risk of adverse outcomes if proper health care is not …

Objectives Patients with dementia experience a wide range of neuropsychiatric symptoms.
These symptoms often cause considerable distress to patients and caregivers, and often …

Aims: To evaluate the behavioural and psychological symptoms of dementia (BPSD), to
determine their correlation with types and stages of dementia and patient demographics …

Context Pain is linked to behaviours and psychological symptoms of dementia (BPSD);
however, it often remains under-recognised in this population. Objectives We aimed to …

Background Agitation is a common neuropsychiatric symptom of Alzheimer disease (AD).
Data are scarce regarding agitation prevalence among community‐dwelling patients with …

Objectives Burdensome symptoms frequently develop as part of the dementia trajectory and
influence quality of life. We explore the course of symptoms and their treatment during …

Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the most common
neurodegenerative earlyonset dementias. Despite the fact that both conditions have a very …

Dementia is a devastating disease with a global impact, and there is an urgent need for
effective interventions to alleviate the accompanying disturbances in behavior, mood, sleep …